The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Inhibitors of the heat shock response: Biology and pharmacology
Abstract
A number of human diseases can be linked to aberrations in protein folding which cause an imbalance in protein homeostasis. Molecular chaperones, including heat shock proteins, act to assist protein folding, stability and activity in the cell. Attention has begun to focus on modulating the expression and/or activity of this group of proteins for the treatment of a wide variety of human diseases. This review will describe the progress made to date in developing pharmacological modulators of the heat shock response, including both agents which affect the entire heat shock response and those that specifically target the HSP70 and HSP90 chaperone families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsp70 chaperones: Cellular functions and molecular mechanism
Mayer, M. P., & Bukau, B. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4464-6 · Cited by 2,865
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Pathways of chaperone-mediated protein folding in the cytosol
Young, J. C., Agashe, V. R., Siegers, K., & Hartl, F. U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1492 · Cited by 1,105
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Heat shock proteins in cancer: chaperones of tumorigenesis
Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., & Ciocca, D. R. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.01.006 · Cited by 957
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Hsp90 isoforms: functions, expression and clinical importance
Subbarao Sreedhar, A., Kalmár, É., Csermely, P., & Shen, Y.-F. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00229-7 · Cited by 620
Hsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis
Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.043 · Cited by 601
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1
Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J. K., Singh, S., Millson, S. H., Clarke, P. A., Naaby-Hansen, S., Stein, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00785-2 · Cited by 542
Self-citationPreclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Molecular chaperones and the stress of oncogenesis
Mosser, D. D., & Morimoto, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207529 · Cited by 502
Marcu, M. G., Chadli, A., Bouhouche, I., Catelli, M., & Neckers, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003701200 · Cited by 502
Banerji, U., O'Donnell, A., Scurr, M., Pacey, S., Stapleton, S., Asad, Y., Simmons, L., Maloney, A., Raynaud, F., Campbell, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.612 · Cited by 488
Self-citationHeat Shock Response Modulators as Therapeutic Tools for Diseases of Protein Conformation
Westerheide, S. D., & Morimoto, R. I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500010200 · Cited by 481
Chaperones increase association of tau protein with microtubules
Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., & Xu, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242720499 · Cited by 461
Jana, N. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.2009 · Cited by 432
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
Westerheide, S. D., Bosman, J. D., Mbadugha, B. N. A., Kawahara, T. L. A., Matsumoto, G., Kim, S., Gu, W., Devlin, J. P., Silverman, R. B., & Morimoto, R. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409267200 · Cited by 427
Hsp70 Inhibits Heat-induced Apoptosis Upstream of Mitochondria by Preventing Bax Translocation
Stankiewicz, A. R., Lachapelle, G., Foo, C. P. Z., Radicioni, S. M., & Mosser, D. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509497200 · Cited by 426
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413 · cited 2×
“HSP90 acetylation has recently been refined to a specific lysine residue (K294) within the middle domain of the chaperone [87].”
BackgroundSick Chaperones, Cellular Stress, and Disease
Macario, A. J. L., & de Macario, E. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050111 · Cited by 372
The hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties
Felts, S. J., Owen, B. A. L., Nguyen, P., Trepel, J., Donner, D. B., & Toft, D. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3305 · Cited by 370
Kelland, L. R., Sharp, S. Y., Rogers, P. M., Myers, T. G., & Workman, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1940 · Cited by 350
Self-citationApproval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Bross, P. F., Kane, R., Farrell, A. T., Abraham, S., Benson, K., Brower, M. E., Bradley, S., Gobburu, J. V., Goheer, A., Lee, S.-L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0781 · Cited by 343
Rational design of shepherdin, a novel anticancer agent
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M. G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.035 · Cited by 341
Inhibitors of the HSP90 Molecular Chaperone: Current Status
(2006) · Advances in Cancer Research · doi:10.1016/s0065-230x(06)95009-x · Cited by 310
Roles of molecular chaperones in protein misfolding diseases
Barral, J. M., Broadley, S. A., Schaffar, G., & Hartl, F. U. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.010 · Cited by 295
Chiosis, G., Timaul, M. N., Lucas, B., Munster, P. N., Zheng, F. F., Sepp-Lorenzino, L., & Rosen, N. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00015-1 · Cited by 288
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
Powers, M. V., & Workman, P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01324 · Cited by 285
Self-citationVígh, L., Literáti, P. N., Horváth, I., Török, Z., Balogh, G., Glatz, A., Kovács, E., Boros, I., Ferdinándy, P., Parkas, B., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1150 · Cited by 278
A New Antifungal Substance of Fungal Origin
DELMOTTE, P., & DELMOTTE-PLAQUEE, J. (1953) · Nature · doi:10.1038/171344a0 · Cited by 271
Rubenstein, R. C., & Zeitlin, P. L. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.2.c259 · Cited by 269
Sydor, J. R., Normant, E., Pien, C. S., Porter, J. R., Ge, J., Grenier, L., Pak, R. H., Ali, J. A., Dembski, M. S., Hudak, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608372103 · Cited by 231
Hsp90: the vulnerable chaperone
Chiosis, G., Vilenchik, M., Kim, J., & Solit, D. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03245-3 · Cited by 229
Yokota, S., Kitahara, M., & Nagata, K. (2000) · PubMed · Cited by 228
Dymock, B. W., Barril, X., Brough, P. A., Cansfield, J. E., Massey, A., McDonald, E., Hubbard, R. E., Surgenor, A., Roughley, S. D., Webb, P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050355z · Cited by 227
Self-citationTriptolide, an Inhibitor of the Human Heat Shock Response That Enhances Stress-induced Cell Death
Westerheide, S. D., Kawahara, T. L. A., Orton, K., & Morimoto, R. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512044200 · Cited by 226
Cheung, K.-M. J., Matthews, T. P., James, K., Rowlands, M. G., Boxall, K. J., Sharp, S. Y., Maloney, A., Roe, S. M., Prodromou, C., Pearl, L. H., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.046 · Cited by 219
Self-citationGuo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E. S. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1799 · Cited by 212
Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity
Fewell, S. W., Smith, C. M., Lyon, M. A., Dumitrescu, T. P., Wipf, P., Day, B. W., & Brodsky, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404857200 · Cited by 211
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Whitesell, L., Bagatell, R., & Falsey, R. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481787 · Cited by 203
Brodsky, J., & Chiosis, G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777811997 · Cited by 200
Schnur, R. C., Corman, M. L., Gallaschun, R. J., Cooper, B. A., Dee, M. F., Doty, J. L., Muzzi, M. L., Moyer, J. D., & DiOrio, C. I. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00019a010 · Cited by 199
The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs
Matter, W. F., Brown, R. F., & Vlahos, C. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90792-j · Cited by 196
Clarke, P. A., Hostein, I., Banerji, U., Stefano, F. D., Maloney, A., Walton, M., Judson, I., & Workman, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203753 · Cited by 194
Self-citationPG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells
Lee, K. Y., Chang, W.-T., Qiu, D., Kao, P. N., & Rosen, G. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13451 · Cited by 184
Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90
He, H., Zatorska, D., Kim, J., Aguirre, J., Llauger, L., She, Y., Wu, N., Immormino, R. M., Gewirth, D. T., & Chiosis, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508078 · Cited by 177
Guo, W., Reigan, P., Siegel, D., Zirrolli, J., Gustafson, D., & Ross, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2029 · Cited by 176
Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues
Yu, X. M., Shen, G., Neckers, L., Blake, H., Holzbeierlein, J., Cronk, B., & Blagg, B. S. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0535864 · Cited by 172
Lee, B. S., Chen, J., Angelidis, C., Jurivich, D. A., & Morimoto, R. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7207 · Cited by 172
Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90
Vilenchik, M., Solit, D., Basso, A., Huezo, H., Lucas, B., He, H., Rosen, N., Spampinato, C., Modrich, P., & Chiosis, G. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.008 · Cited by 171
Banerji, U., Walton, M., Raynaud, F., Grimshaw, R., Kelland, L., Valenti, M., Judson, I., & Workman, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0518 · Cited by 164
Self-citationInteraction of Radicicol with Members of the Heat Shock Protein 90 Family of Molecular Chaperones
Schulte, T. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.9.1435 · Cited by 161
McCollum, A. K., TenEyck, C. J., Sauer, B. M., Toft, D. O., & Erlichman, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1629 · Cited by 157
Quercetin Suppresses Heat Shock Response by Down-Regulation of HSF1
Nagai, N., Nakai, A., & Nagata, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1447 · Cited by 156
Schmitt, E., Maingret, L., Puig, P., Rérole, A.-L., Ghiringhelli, F., Hammann, A., Solary, É., Kroemer, G., & Garrido, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3778 · Cited by 153
17AAG: low target binding affinity and potent cell activity--finding an explanation.
Chiosis, G., Huezo, H., Rosen, N. X., Mimnaugh, E. G., Whitesell, L. J., & Neckers, L. (2003) · PubMed · Cited by 149
Sharp, S. Y., Prodromou, C., Boxall, K. J., Powers, M. V., Holmes, J. L., Box, G., Matthews, T. P., Cheung, K.-M. J., Kalusa, A., James, K. E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0149 · Cited by 145
Self-citationStructure of the N-terminal Domain of GRP94
Soldano, K. L., Jivan, A., Nicchitta, C. V., & Gewirth, D. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308661200 · Cited by 140
Soga, S., Neckers, L. M., Schulte, T. W., Shiotsu, Y., Akasaka, K., Narumi, H., Agatsuma, T., IKUINA, Y., Murakata, C., Tamaoki, T., et al. (1999) · PubMed · Cited by 133
Harst, A., Lin, H.-Y., & Obermann, W. (2005) · Biochemical Journal · doi:10.1042/bj20041283 · Cited by 121
Kim, D., Kim, S., & Li, G. C. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9840 · Cited by 121
Nadeau, K. C., Nadler, S. G., Saulnier, M. G., Walsh, C. T., & Tepper, M. A. (1994) · Biochemistry · doi:10.1021/bi00175a027 · Cited by 116
Sharp, S. Y., Boxall, K. J., Rowlands, M., Prodromou, C., Roe, S. M., Maloney, A., Powers, M. V., Clarke, P. A., Box, G., Sanderson, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3473 · Cited by 112
Self-citationRole of the Retinoblastoma Protein in Differentiation and Senescence
Thomas, D. M., Yang, H.-S., Alexander, K., & Hinds, P. W. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.235 · Cited by 100
Rossi, A., Ciafrè, S., Balsamo, M., Pierimarchi, P., & Santoro, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4282 · Cited by 99
Hsp90 Inhibitors in the Clinic
Pacey, S., Banerj, U., Judson, I. R., & Workman, P. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_14 · Cited by 98
Self-citationGrammatikakis, N., Vultur, A., Ramana, C. V., Siganou, A., Schweinfest, C. W., Watson, D. K., & Raptis, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109200200 · Cited by 97
Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors
Gyurkocza, B., Plescia, J., Raskett, C. M., Garlick, D. S., Lowry, P. A., Carter, B. Z., Andreeff, M., Meli, M., Colombo, G., & Altieri, D. C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj300 · Cited by 94
Meli, M., Pennati, M., Curto, M., Daidone, M. G., Plescia, J., Toba, S., Altieri, D. C., Zaffaroni, N., & Colombo, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060836y · Cited by 93
Histone modification enzymes: novel targets for cancer drugs
Kristeleit, R. S., Stimson, L., Workman, P., & Aherne, W. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.1.135 · Cited by 86
Self-citationTyrosine protein kinase activity in the DMBA-induced rat mammary tumor: Inhibition by quercetin
Levy, J., Teuerstein, I., Marbach, M., Radian, S., & Sharoni, Y. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80264-8 · Cited by 80
Mamelak, D., Mylvaganam, M., Whetstone, H., Hartmann, E., Lennarz, W. J., Wyrick, P. B., Raulston, J. E., Han, H., Hoffman, P. S., & Lingwood, C. A. (2001) · Biochemistry · doi:10.1021/bi001643u · Cited by 75
Ligand Interactions in the Adenosine Nucleotide-binding Domain of the Hsp90 Chaperone, GRP94
Rosser, M. F. N., & Nicchitta, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001477200 · Cited by 75
Recombinant antibodies: a natural partner in combinatorial antifungal therapy
Matthews, R., & Burnie, J. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.11.032 · Cited by 69
Radicicol, an Agent Inducing the Reversal of Transformed Phenotypes ofsrc-Transformed Fibroblasts
Kwon, H. J., Yoshida, M., Abe, K., et al. (1992) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.56.538 · Cited by 68
Identification of an Inhibitor of hsc70-mediated Protein Translocation and ATP Hydrolysis
Fewell, S. W., Day, B. W., & Brodsky, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008535200 · Cited by 66
Asea, A. A. A., Ara, G., Teicher, B. A., et al. (2001) · International Journal of Hyperthermia · doi:10.1080/02656730110053146 · Cited by 62
Dechsupa, N., Kothan, S., Vergote, J., Léger, G., Martineau, A., Beranger, S., Kosanlavit, R., Moretti, J., & Mankhetkorn, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.1.3548 · Cited by 59
Feedback Regulation of the Heat Shock Response
Voellmy, R. W. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_2 · Cited by 42
Marcu, M. G., & Neckers, L. Μ. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481804 · Cited by 31
Turbyville, T. J., Wijeratne, E. M. K., Whitesell, L. J., & Gunatilaka, A. A. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0050 · Cited by 29
Jurivich, D. A., Pangas, S. A., Qiu, L., & Welk, J. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1669 · Cited by 25
Clarke, P. A., Powers, M. V., & Workman, P. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch37 · Cited by 2
Self-citation
Cited by
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 891
Self-citationPharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
The Hsp90 molecular chaperone: an open and shut case for treatment
Pearl, L. H., Prodromou, C., & Workman, P. (2008) · Biochemical Journal · doi:10.1042/bj20071640 · Cited by 447
Self-citationA Small Molecule Inhibitor of Inducible Heat Shock Protein 70
Leu, J. I.-J., Pimkina, J., Frank, A., Murphy, M. E., & George, D. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.023 · Cited by 441
Metadata
- Authors
- Powers, M. V., & Workman, P.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2007-05-25
- Volume
- 581
- Issue
- 19
- Pages
- 3758-3769
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2016976719
- Cited by
- 320
- References
- 89
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.